Press What’s news at AbelsonTaylor Group
Select category
MM+M Agency 100 StoryCast, AbelsonTaylor: Working in and Living With Rare Disease
EPISODE SUMMARY
Supporting rare disease brands takes a special type of team. These brands require a particular level of authenticity in their patient-centric approach – even when the promotional messaging is for HCPs. Let’s dig beyond the surface of rare disease brand support and talk to an engagement strategy team that has been leading the charge on innovation in this space both as marketers and as a mother of a child with a rare disease.
SHOW CONTRIBUTORS
Larry Dobrow
Erica Rivera
Lisa Chengary
Media Contact:
Recent Posts
Social Media Marketing Trends 2025 Report
Thenetworkone just released its annual industry resource on social media trends, including expert insights from AT Group’s Associate Director of Engagement...
In the News Read more Social Media Marketing Trends 2025 ReportAn Indie POV on the Omnicom-Interpublic Merger
AT Group President Jeff Berg recently joined MM+M’s Jack O’Brien to discuss the future of the medical advertising industry in...
Read Press Read more An Indie POV on the Omnicom-Interpublic MergerHow will pharma marketers crack the AI code in 2025?
MM+M January 3, 2025 In the article, “How will pharma marketers crack the AI code in 2025?” AbelsonTaylor Group’s Amy...
In the News Read more How will pharma marketers crack the AI code in 2025?Connect with us
Find out what's top of mind for the people reimagining health and wellness advertising.